Skip to Main Content Go to Sitemap
SickKids

Vitamin B12, serum or plasma

Alternate test name

Cyanocobalamin

Lab area
Clinical Biochemistry - General
Method and equipment
Equipment : Roche Cobas Pro e801
 
Method : Competition principle. Total duration of assay: 27 minutes.
▪ 1st incubation: By incubating the sample (9 µL) with the vitamin B12 pretreatment 1 and pretreatment 2, bound vitamin B12 is released. 
▪ 2nd incubation: By incubating the pretreated sample with the ruthenium‑labeled intrinsic factor, a vitamin B12‑binding protein complex is formed, the amount of which is dependent upon the analyte concentration in the sample.
▪ 3rd incubation: After addition of streptavidin-coated microparticles and vitamin B12 labeled with biotin, the still-vacant sites of the ruthenium‑labeled intrinsic factor become occupied, with formation of a ruthenium‑labeled intrinsic factor vitamin B12 biotin complex. The entire complex becomes bound to the solid phase via interaction of biotin and streptavidin. 
▪ The reaction mixture is aspirated into the measuring cell where the microparticles are magnetically captured onto the surface of the electrode. Unbound substances are then removed with ProCell II M. Application of a voltage to the electrode then induces chemiluminescent emission which is measured by a photomultiplier.
▪ Results are determined via a calibration curve which is instrument specifically generated by 2‑point calibration and a master curve provided via the cobas link.
Expected turn-around time
STAT/ Urgent: 6 Hours Routine: 24 Hours
Specimen type

Serum, Plasma Lithium Heparin

Specimen requirements

150 uL

Storage and transportation

Frozen

Shipping information
The Hospital for Sick Children
Rapid Response Laboratory
555 University Avenue, Room 3642
Toronto, ON
Canada
M5G 1X8
Phone: 416-813-7200
Toll Free: 1-855-381-3212
Hours: 7 days/week, 24 hours/day
Background and clinical significance

Vitamin B12 (cobalamin) in serum is bound to two proteins: transcobalamin (TC) and haptocorrin (HC). The transcobalamin-vitamin B12 complex is called holotranscobalamin (HoloTC). HoloTC contains the biologically available cobalamin as only HoloTC promotes the uptake of cobalamin by all cells via specific receptors. Methods based on specific anti-TC antibodies have been available and confirm the usefulness of HoloTC for diagnosing B12 deficiency. As expected, HoloTC levels are low in patients with biochemical signs of vitamin B12 deficiency. Notably, low values have been reported in vegetarians, vegans, and in populations with a low intake of vitamin B12. In addition, low levels of HoloTC (but not vitamin B12) in serum were reported in patients with Alzheimer’s disease compared to levels of HoloTC in a healthy control group.

Back to Top